BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012;142:1100-1101.e2. [PMID: 22326433 DOI: 10.1053/j.gastro.2012.01.034] [Cited by in Crossref: 259] [Cited by in F6Publishing: 227] [Article Influence: 28.8] [Reference Citation Analysis]
Number Citing Articles
1 Italian Association for the Study of the Liver (AISF). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig Liver Dis. 2017;49:471-483. [PMID: 28215516 DOI: 10.1016/j.dld.2017.01.147] [Cited by in Crossref: 161] [Cited by in F6Publishing: 140] [Article Influence: 40.3] [Reference Citation Analysis]
2 Jonsson AL, Bäckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 2017;14:79-87. [PMID: 27905479 DOI: 10.1038/nrcardio.2016.183] [Cited by in Crossref: 192] [Cited by in F6Publishing: 161] [Article Influence: 38.4] [Reference Citation Analysis]
3 Norris G, Porter C, Jiang C, Blesso C. Dietary Milk Sphingomyelin Reduces Systemic Inflammation in Diet-Induced Obese Mice and Inhibits LPS Activity in Macrophages. Beverages 2017;3:37. [DOI: 10.3390/beverages3030037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
4 Gil-Gómez A, Brescia P, Rescigno M, Romero-Gómez M. Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. Semin Liver Dis 2021;41:191-205. [PMID: 34107545 DOI: 10.1055/s-0041-1723752] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mani V, Hollis JH, Gabler NK. Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab (Lond) 2013;10:6. [PMID: 23305038 DOI: 10.1186/1743-7075-10-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 8.8] [Reference Citation Analysis]
6 Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Infection. 2018;. [PMID: 30066228 DOI: 10.1007/s15010-018-1185-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
7 Ghosh SS, He H, Wang J, Gehr TW, Ghosh S. Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects. Tissue Barriers 2018;6:e1425085. [PMID: 29420166 DOI: 10.1080/21688370.2018.1425085] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
8 Hashimoto R, Kakigi R, Miyamoto Y, Nakamura K, Itoh S, Daida H, Okada T, Katoh Y. JAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages. Eur J Pharmacol 2020;871:172940. [PMID: 31968212 DOI: 10.1016/j.ejphar.2020.172940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
9 Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci 2021;22:4156. [PMID: 33923817 DOI: 10.3390/ijms22084156] [Reference Citation Analysis]
10 Kjær MB, George J, Kazankov K, Grønbæk H. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy? Expert Rev Gastroenterol Hepatol 2021;15:51-64. [PMID: 32878486 DOI: 10.1080/17474124.2020.1817740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 André P, Laugerette F, Féart C. Metabolic Endotoxemia: A Potential Underlying Mechanism of the Relationship between Dietary Fat Intake and Risk for Cognitive Impairments in Humans? Nutrients 2019;11:E1887. [PMID: 31412673 DOI: 10.3390/nu11081887] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
12 Wu H, Wang Y, Li H, Meng L, Zheng N, Wang J. Effect of Food Endotoxin on Infant Health. Toxins (Basel) 2021;13:298. [PMID: 33922125 DOI: 10.3390/toxins13050298] [Reference Citation Analysis]
13 Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Nonalcoholic fatty liver disease: Evolving paradigms. World J Gastroenterol. 2017;23:6571-6592. [PMID: 29085206 DOI: 10.3748/wjg.v23.i36.6571] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 62] [Article Influence: 26.0] [Reference Citation Analysis]
14 Kirpich IA, Marsano LS, McClain CJ. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem. 2015;48:923-930. [PMID: 26151226 DOI: 10.1016/j.clinbiochem.2015.06.023] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 21.3] [Reference Citation Analysis]
15 Bengmark S. Gut microbiota, immune development and function. Pharmacol Res. 2013;69:87-113. [PMID: 22989504 DOI: 10.1016/j.phrs.2012.09.002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 90] [Article Influence: 13.0] [Reference Citation Analysis]
16 Rebai R, Jasmin L, Boudah A. Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats. Biomedicine & Pharmacotherapy 2021;135:111246. [DOI: 10.1016/j.biopha.2021.111246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Seaman DR. Toxins, Toxicity, and Endotoxemia: A Historical and Clinical Perspective for Chiropractors. J Chiropr Humanit 2016;23:68-76. [PMID: 27920621 DOI: 10.1016/j.echu.2016.07.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Feng D, Zou J, Su D, Mai H, Zhang S, Li P, Zheng X. Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE-/- mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. Nutr Metab (Lond) 2019;16:79. [PMID: 31788011 DOI: 10.1186/s12986-019-0410-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
19 Jennison E, Byrne CD. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clin Mol Hepatol 2021;27:22-43. [PMID: 33291863 DOI: 10.3350/cmh.2020.0129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
20 Bernabé BP, Tussing-Humphreys L, Rackers HS, Welke L, Mantha A, Kimmel MC. Improving Mental Health for the Mother-Infant Dyad by Nutrition and the Maternal Gut Microbiome. Gastroenterol Clin North Am 2019;48:433-45. [PMID: 31383280 DOI: 10.1016/j.gtc.2019.04.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
21 Hulston CJ, Churnside AA, Venables MC. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr 2015;113:596-602. [PMID: 25630516 DOI: 10.1017/S0007114514004097] [Cited by in Crossref: 79] [Cited by in F6Publishing: 25] [Article Influence: 13.2] [Reference Citation Analysis]
22 Kaliannan K, Wang B, Li XY, Kim KJ, Kang JX. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia.Sci Rep. 2015;5:11276. [PMID: 26062993 DOI: 10.1038/srep11276] [Cited by in Crossref: 172] [Cited by in F6Publishing: 136] [Article Influence: 28.7] [Reference Citation Analysis]
23 Breusing N, Lagerpusch M, Engstler AJ, Bergheim I, Mueller MJ, Bosy-Westphal A. Influence of Energy Balance and Glycemic Index on Metabolic Endotoxemia in Healthy Men. J Am Coll Nutr 2017;36:72-9. [PMID: 28060600 DOI: 10.1080/07315724.2016.1156036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Singh P, Ochoa-Allemant P, Brown J, Perides G, Freedman SD, Martin CR. Effect of polyunsaturated fatty acids on postnatal ileum development using the fat-1 transgenic mouse model. Pediatr Res 2019;85:556-65. [PMID: 30653193 DOI: 10.1038/s41390-019-0284-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Tilg H. Cruciferous vegetables: prototypic anti-inflammatory food components. Clin Phytosci 2015;1. [DOI: 10.1186/s40816-015-0011-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146:357-373. [PMID: 24315827 DOI: 10.1053/j.gastro.2013.11.051] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 13.8] [Reference Citation Analysis]
27 Riccio P, Rossano R. Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis. Neurotherapeutics 2018;15:75-91. [PMID: 29067566 DOI: 10.1007/s13311-017-0581-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 21.0] [Reference Citation Analysis]
28 O'Connor EM, O'Herlihy EA, O'Toole PW. Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects. Proc Nutr Soc 2014;73:441-51. [PMID: 24824449 DOI: 10.1017/S0029665114000597] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
29 Shil A, Olusanya O, Ghufoor Z, Forson B, Marks J, Chichger H. Artificial Sweeteners Disrupt Tight Junctions and Barrier Function in the Intestinal Epithelium through Activation of the Sweet Taste Receptor, T1R3. Nutrients 2020;12:E1862. [PMID: 32580504 DOI: 10.3390/nu12061862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
30 Grakoui A, Crispe IN. Presentation of hepatocellular antigens. Cell Mol Immunol 2016;13:293-300. [PMID: 26924525 DOI: 10.1038/cmi.2015.109] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
31 Pang J, Xu W, Zhang X, Wong GL, Chan AW, Chan H, Tse C, Shu SS, Choi PC, Chan HL, Yu J, Wong VW. Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2017;46:175-82. [DOI: 10.1111/apt.14119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
32 Marlicz W, Yung DE, Skonieczna-Żydecka K, Loniewski I, van Hemert S, Loniewska B, Koulaouzidis A. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Rev Gastroenterol Hepatol 2017;11:961-78. [PMID: 28618973 DOI: 10.1080/17474124.2017.1343664] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
33 Carey AN, Gildawie KR, Rovnak A, Thangthaeng N, Fisher DR, Shukitt-Hale B. Blueberry supplementation attenuates microglia activation and increases neuroplasticity in mice consuming a high-fat diet. Nutr Neurosci 2019;22:253-63. [PMID: 28931353 DOI: 10.1080/1028415X.2017.1376472] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
34 Camilleri M. High-Fat Diet, Dysbiosis, and Gastrointestinal and Colonic Transit: Is There a Missing Link? Cell Mol Gastroenterol Hepatol 2016;2:257-8. [PMID: 28174717 DOI: 10.1016/j.jcmgh.2016.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Johnson AM, Costanzo A, Gareau MG, Armando AM, Quehenberger O, Jameson JM, Olefsky JM. High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One 2015;10:e0122195. [PMID: 25837594 DOI: 10.1371/journal.pone.0122195] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 9.8] [Reference Citation Analysis]
36 Fan MZ, Archbold T. Novel and disruptive biological strategies for resolving gut health challenges in monogastric food animal production. Anim Nutr 2015;1:138-43. [PMID: 29767174 DOI: 10.1016/j.aninu.2015.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Lopresti AL. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Adv Nutr 2018;9:41-50. [PMID: 29438458 DOI: 10.1093/advances/nmx011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 38.0] [Reference Citation Analysis]
38 Lai ZL, Tseng CH, Ho HJ, Cheung CKY, Lin JY, Chen YJ, Cheng FC, Hsu YC, Lin JT, El-Omar EM, Wu CY. Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice. Sci Rep 2018;8:15625. [PMID: 30353027 DOI: 10.1038/s41598-018-33893-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 13.3] [Reference Citation Analysis]
39 Sears B, Perry M. The role of fatty acids in insulin resistance. Lipids Health Dis 2015;14:121. [PMID: 26415887 DOI: 10.1186/s12944-015-0123-1] [Cited by in Crossref: 197] [Cited by in F6Publishing: 154] [Article Influence: 32.8] [Reference Citation Analysis]
40 Paparo L, Calignano A, Tocchetti CG, Di Scala C, Russo R, Bonaduce D, Canani RB. The Influence of Fiber on Gut Microbiota: Butyrate as Molecular Player Involved in the Beneficial Interplay Between Dietary Fiber and Cardiovascular Health. Dietary Fiber for the Prevention of Cardiovascular Disease. Elsevier; 2017. pp. 61-71. [DOI: 10.1016/b978-0-12-805130-6.00004-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Wong VW, Wong GL, Chan HY, Yeung DK, Chan RS, Chim AM, Chan CK, Tse YK, Woo J, Chu WC. Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study. Aliment Pharmacol Ther. 2015;42:731-740. [PMID: 26202818 DOI: 10.1111/apt.13327] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
42 McSharry C, Spears M, Chaudhuri R, Cameron EJ, Husi H, Thomson NC. Increased sputum endotoxin levels are associated with an impaired lung function response to oral steroids in asthmatic patients. J Allergy Clin Immunol 2014;134:1068-75. [PMID: 25262463 DOI: 10.1016/j.jaci.2014.08.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
43 Hoque R, Mehal WZ. Inflammasomes in pancreatic physiology and disease. Am J Physiol Gastrointest Liver Physiol 2015;308:G643-51. [PMID: 25700081 DOI: 10.1152/ajpgi.00388.2014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
44 Patel SS, Siddiqui MS. Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. Drugs. 2019;79:75-84. [PMID: 30588564 DOI: 10.1007/s40265-018-1040-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
45 Selhub EM, Logan AC, Bested AC. Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry. J Physiol Anthropol 2014;33:2. [PMID: 24422720 DOI: 10.1186/1880-6805-33-2] [Cited by in Crossref: 118] [Cited by in F6Publishing: 77] [Article Influence: 16.9] [Reference Citation Analysis]
46 Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, Del Ben M. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients 2020;12:E2762. [PMID: 32927776 DOI: 10.3390/nu12092762] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
47 Louzada ER, Ribeiro SML. Synbiotic supplementation, systemic inflammation, and symptoms of brain disorders in elders: A secondary study from a randomized clinical trial. Nutritional Neuroscience 2020;23:93-100. [DOI: 10.1080/1028415x.2018.1477349] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
48 Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development. J Endocr Soc. 2020;4:bvz039. [PMID: 32099951 DOI: 10.1210/jendso/bvz039] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 49.0] [Reference Citation Analysis]
49 Frame LA, Costa E, Jackson SA. Current explorations of nutrition and the gut microbiome: a comprehensive evaluation of the review literature. Nutrition Reviews 2020;78:798-812. [DOI: 10.1093/nutrit/nuz106] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 22.0] [Reference Citation Analysis]
50 Udompornpitak K, Bhunyakarnjanarat T, Charoensappakit A, Dang CP, Saisorn W, Leelahavanichkul A. Lipopolysaccharide-Enhanced Responses against Aryl Hydrocarbon Receptor in FcgRIIb-Deficient Macrophages, a Profound Impact of an Environmental Toxin on a Lupus-Like Mouse Model. Int J Mol Sci 2021;22:4199. [PMID: 33919603 DOI: 10.3390/ijms22084199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Dong TS, Gupta A. Influence of Early Life, Diet, and the Environment on the Microbiome. Clin Gastroenterol Hepatol. 2019;17:231-242. [PMID: 30196160 DOI: 10.1016/j.cgh.2018.08.067] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 15.7] [Reference Citation Analysis]
52 Janssen AW, Kersten S. Potential mediators linking gut bacteria to metabolic health: a critical view. J Physiol. 2017;595:477-487. [PMID: 27418465 DOI: 10.1113/jp272476] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 6.6] [Reference Citation Analysis]
53 van Niekerk G, du Toit A, Loos B, Engelbrecht AM. Nutrient excess and autophagic deficiency: explaining metabolic diseases in obesity. Metabolism 2018;82:14-21. [PMID: 29289514 DOI: 10.1016/j.metabol.2017.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
54 Mohammad S, Thiemermann C. Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front Immunol 2020;11:594150. [PMID: 33505393 DOI: 10.3389/fimmu.2020.594150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
55 Nguyen TTB, Jin YY, Chung HJ, Hong ST. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases. Molecules 2017;22:E1795. [PMID: 29064399 DOI: 10.3390/molecules22101795] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
56 Tungland B. Short-Chain Fatty Acid Production and Functional Aspects on Host Metabolism. Human Microbiota in Health and Disease. Elsevier; 2018. pp. 37-106. [DOI: 10.1016/b978-0-12-814649-1.00002-8] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
57 Mukherjee P, Hough G, Chattopadhyay A, Navab M, Fogelman HR, Meriwether D, Williams K, Bensinger S, Moller T, Faull KF, Lusis AJ, Iruela-Arispe ML, Bostrom KI, Tontonoz P, Reddy ST, Fogelman AM. Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum. J Lipid Res 2017;58:1636-47. [PMID: 28592401 DOI: 10.1194/jlr.M076554] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
58 Zhang J, Tu M, Liu Z, Zhang G. Soluble epoxide hydrolase as a therapeutic target for obesity-induced disorders: roles of gut barrier function involved. Prostaglandins Leukot Essent Fatty Acids 2020;162:102180. [PMID: 33038829 DOI: 10.1016/j.plefa.2020.102180] [Reference Citation Analysis]
59 Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.Biomolecules. 2019;9. [PMID: 31779136 DOI: 10.3390/biom9120780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
60 de Punder K, Pruimboom L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol 2015;6:223. [PMID: 26029209 DOI: 10.3389/fimmu.2015.00223] [Cited by in Crossref: 112] [Cited by in F6Publishing: 89] [Article Influence: 18.7] [Reference Citation Analysis]
61 Peleman C, Camilleri M. Rifaximin, Microbiota Biology, and Hepatic Encephalopathy. Clin Transl Gastroenterol 2016;7:e195. [PMID: 27711069 DOI: 10.1038/ctg.2016.52] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
62 Cheru L, Saylor CF, Lo J. Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation. Curr Obes Rep 2019;8:165-74. [PMID: 30847735 DOI: 10.1007/s13679-019-00332-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
63 Camilleri M, Ford AC. Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.Handb Exp Pharmacol. 2017;239:75-113. [PMID: 27995391 DOI: 10.1007/164_2016_102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
64 Boutagy NE, McMillan RP, Frisard MI, Hulver MW. Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie. 2016;124:11-20. [PMID: 26133659 DOI: 10.1016/j.biochi.2015.06.020] [Cited by in Crossref: 182] [Cited by in F6Publishing: 149] [Article Influence: 30.3] [Reference Citation Analysis]
65 Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M, Cannito S. Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 2020;689:108445. [PMID: 32524998 DOI: 10.1016/j.abb.2020.108445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
66 Ponzo V, Fedele D, Goitre I, Leone F, Lezo A, Monzeglio C, Finocchiaro C, Ghigo E, Bo S. Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM). Nutrients 2019;11:E330. [PMID: 30717458 DOI: 10.3390/nu11020330] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
67 Sharpton SR, Schnabl B, Knight R, Loomba R. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. Cell Metab 2021;33:21-32. [PMID: 33296678 DOI: 10.1016/j.cmet.2020.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
68 Ferguson JF, Ryan MF, Gibney ER, Brennan L, Roche HM, Reilly MP. Dietary isoflavone intake is associated with evoked responses to inflammatory cardiometabolic stimuli and improved glucose homeostasis in healthy volunteers. Nutr Metab Cardiovasc Dis 2014;24:996-1003. [PMID: 24875672 DOI: 10.1016/j.numecd.2014.03.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
69 Camilleri M, Lyle BJ, Madsen KL, Sonnenburg J, Verbeke K, Wu GD. Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations. Am J Physiol Gastrointest Liver Physiol 2019;317:G17-39. [PMID: 31125257 DOI: 10.1152/ajpgi.00063.2019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
70 Tilg H, Moschen AR. Evolving therapies for non-alcoholic steatohepatitis. Expert Opin Drug Discov 2014;9:687-96. [PMID: 24766298 DOI: 10.1517/17460441.2014.911283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
71 Ghosh SS, Wang J, Yannie PJ, Sandhu YK, Korzun WJ, Ghosh S. Dietary Supplementation with Galactooligosaccharides Attenuates High-Fat, High-Cholesterol Diet-Induced Glucose Intolerance and Disruption of Colonic Mucin Layer in C57BL/6 Mice and Reduces Atherosclerosis in Ldlr-/- Mice. J Nutr 2020;150:285-93. [PMID: 31586202 DOI: 10.1093/jn/nxz233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
72 Zhou H, Urso CJ, Jadeja V. Saturated Fatty Acids in Obesity-Associated Inflammation. J Inflamm Res 2020;13:1-14. [PMID: 32021375 DOI: 10.2147/JIR.S229691] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 25.0] [Reference Citation Analysis]
73 Onyango AN. Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance. Oxid Med Cell Longev 2018;2018:4321714. [PMID: 30116482 DOI: 10.1155/2018/4321714] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
74 Khoshbin K, Camilleri M. Effects of dietary components on intestinal permeability in health and disease. Am J Physiol Gastrointest Liver Physiol 2020;319:G589-608. [PMID: 32902315 DOI: 10.1152/ajpgi.00245.2020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
75 Ghosh SS, Bie J, Wang J, Ghosh S. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation. PLoS One 2014;9:e108577. [PMID: 25251395 DOI: 10.1371/journal.pone.0108577] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 11.7] [Reference Citation Analysis]
76 Tilg H, Adolph TE, Moschen AR. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology. 2021;73:833-842. [PMID: 32780879 DOI: 10.1002/hep.31518] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 35.0] [Reference Citation Analysis]
77 Greenway F, Wang S, Heiman M. A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report. Beneficial Microbes 2014;5:29-32. [DOI: 10.3920/bm2012.0063] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
78 Schachter J, Martel J, Lin CS, Chang CJ, Wu TR, Lu CC, Ko YF, Lai HC, Ojcius DM, Young JD. Effects of obesity on depression: A role for inflammation and the gut microbiota. Brain Behav Immun 2018;69:1-8. [PMID: 28888668 DOI: 10.1016/j.bbi.2017.08.026] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
79 López-Fandiño R. Role of dietary lipids in food allergy. Crit Rev Food Sci Nutr 2020;60:1797-814. [PMID: 31032635 DOI: 10.1080/10408398.2019.1602025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
80 Lee ES, Song EJ, Nam YD, Lee SY. Probiotics in human health and disease: from nutribiotics to pharmabiotics. J Microbiol 2018;56:773-82. [PMID: 30353462 DOI: 10.1007/s12275-018-8293-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 12.3] [Reference Citation Analysis]
81 Ribeiro SM, Kehayias JJ. Sarcopenia and the analysis of body composition. Adv Nutr 2014;5:260-7. [PMID: 24829472 DOI: 10.3945/an.113.005256] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
82 Li H, Sureda A, Devkota HP, Pittalà V, Barreca D, Silva AS, Tewari D, Xu S, Nabavi SM. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnology Advances 2020;38:107343. [DOI: 10.1016/j.biotechadv.2019.01.010] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 72.0] [Reference Citation Analysis]
83 Velasquez MT. Altered Gut Microbiota: A Link Between Diet and the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2018;16:321-8. [DOI: 10.1089/met.2017.0163] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
84 Burcelin R, Chabo C, Blasco-baque V, Sérino M, Amar J. Le microbiote intestinal à l’origine de nouvelles perspectives thérapeutiques pour les maladies métaboliques ? Med Sci (Paris) 2013;29:800-6. [DOI: 10.1051/medsci/2013298021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
85 Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, Shen XZ. The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease. Drug Des Devel Ther 2019;13:2249-70. [PMID: 31308634 DOI: 10.2147/DDDT.S207277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
86 Leigh SJ, Morris MJ. Diet, inflammation and the gut microbiome: Mechanisms for obesity-associated cognitive impairment. Biochim Biophys Acta Mol Basis Dis 2020;1866:165767. [PMID: 32171891 DOI: 10.1016/j.bbadis.2020.165767] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 19.0] [Reference Citation Analysis]
87 Matsumoto K, Ichimura M, Tsuneyama K, Moritoki Y, Tsunashima H, Omagari K, Hara M, Yasuda I, Miyakawa H, Kikuchi K. Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis. PLoS One 2017;12:e0175406. [PMID: 28632732 DOI: 10.1371/journal.pone.0175406] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
88 Li J, Sapper TN, Mah E, Moller MV, Kim JB, Chitchumroonchokchai C, McDonald JD, Bruno RS. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability. J Nutr Biochem 2017;41:34-41. [PMID: 28038359 DOI: 10.1016/j.jnutbio.2016.12.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
89 Maranduba CM, De Castro SB, de Souza GT, Rossato C, da Guia FC, Valente MA, Rettore JV, Maranduba CP, de Souza CM, do Carmo AM, Macedo GC, Silva Fde S. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res 2015;2015:931574. [PMID: 25759850 DOI: 10.1155/2015/931574] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
90 Zhou HC, Guo CA, Yu WW, Yan XY, Long JP, Liu ZC, Liang XQ, Liu HB. Zizyphus jujuba cv. Muzao polysaccharides enhance intestinal barrier function and improve the survival of septic mice. J Food Biochem 2021;45:e13722. [PMID: 33855723 DOI: 10.1111/jfbc.13722] [Reference Citation Analysis]
91 Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68:280-295. [PMID: 29154964 DOI: 10.1016/j.jhep.2017.11.014] [Cited by in Crossref: 257] [Cited by in F6Publishing: 220] [Article Influence: 64.3] [Reference Citation Analysis]
92 Milan AM, Pundir S, Pileggi CA, Markworth JF, Lewandowski PA, Cameron-Smith D. Comparisons of the Postprandial Inflammatory and Endotoxaemic Responses to Mixed Meals in Young and Older Individuals: A Randomised Trial. Nutrients 2017;9:E354. [PMID: 28368340 DOI: 10.3390/nu9040354] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
93 Mastrocola R, Ferrocino I, Liberto E, Chiazza F, Cento AS, Collotta D, Querio G, Nigro D, Bitonto V, Cutrin JC, Rantsiou K, Durante M, Masini E, Aragno M, Cordero C, Cocolin L, Collino M. Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study. J Nutr Biochem 2018;55:185-99. [PMID: 29539590 DOI: 10.1016/j.jnutbio.2018.02.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
94 Suppli MP, Bagger JI, Lelouvier B, Broha A, Demant M, Kønig MJ, Strandberg C, Lund A, Vilsbøll T, Knop FK. Hepatic microbiome in healthy lean and obese humans. JHEP Rep 2021;3:100299. [PMID: 34169247 DOI: 10.1016/j.jhepr.2021.100299] [Reference Citation Analysis]
95 Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. Int J Mol Sci 2021;22:8161. [PMID: 34360923 DOI: 10.3390/ijms22158161] [Reference Citation Analysis]
96 Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol 2020;11:2144. [PMID: 33042125 DOI: 10.3389/fimmu.2020.02144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Korpela K, Zijlmans MA, Kuitunen M, Kukkonen K, Savilahti E, Salonen A, de Weerth C, de Vos WM. Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use. Microbiome 2017;5:26. [PMID: 28253911 DOI: 10.1186/s40168-017-0245-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 12.8] [Reference Citation Analysis]
98 Kim MS, Hwang SS, Park EJ, Bae JW. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ Microbiol Rep 2013;5:765-75. [PMID: 24115628 DOI: 10.1111/1758-2229.12079] [Cited by in Crossref: 42] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
99 Tang ZZ, Chen G, Hong Q, Huang S, Smith HM, Shah RD, Scholz M, Ferguson JF. Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites. Front Genet 2019;10:454. [PMID: 31164901 DOI: 10.3389/fgene.2019.00454] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 19.5] [Reference Citation Analysis]
100 Giusti L, Gabriele M, Penno G, Garofolo M, Longo V, Del Prato S, Lucchesi D, Pucci L. A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells. Oxid Med Cell Longev 2017;2017:1026268. [PMID: 28386305 DOI: 10.1155/2017/1026268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
101 Sharifov OF, Nayyar G, Ternovoy VV, Palgunachari MN, Garber DW, Anantharamaiah G, Gupta H. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A. Innate Immun 2014;20:867-80. [PMID: 24323453 DOI: 10.1177/1753425913514621] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
102 Vallianou NG, Stratigou T, Tsagarakis S. Microbiome and diabetes: Where are we now? Diabetes Res Clin Pract. 2018;146:111-118. [PMID: 30342053 DOI: 10.1016/j.diabres.2018.10.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 14.3] [Reference Citation Analysis]
103 Piya MK, Harte AL, Mcternan PG. Metabolic endotoxaemia: is it more than just a gut feeling? Current Opinion in Lipidology 2013;24:78-85. [DOI: 10.1097/mol.0b013e32835b4431] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
104 Duffy LC, Raiten DJ, Hubbard VS, Starke-Reed P. Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism. J Nutr. 2015;145:1123S-1130S. [PMID: 25833886 DOI: 10.3945/jn.114.194936] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
105 Gu Y, Yu S, Park JY, Harvatine K, Lambert JD. Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice. J Nutr Biochem 2014;25:439-45. [PMID: 24561154 DOI: 10.1016/j.jnutbio.2013.12.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
106 Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 2020;20:40-54. [DOI: 10.1038/s41577-019-0198-4] [Cited by in Crossref: 179] [Cited by in F6Publishing: 149] [Article Influence: 89.5] [Reference Citation Analysis]
107 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 2018;15:785. [PMID: 29785003 DOI: 10.1038/s41575-018-0031-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 6.7] [Reference Citation Analysis]
108 Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier function and metabolic/liver diseases. Liver Research 2020;4:81-7. [DOI: 10.1016/j.livres.2020.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
109 Honka H, Mäkinen J, Hannukainen JC, Tarkia M, Oikonen V, Teräs M, Fagerholm V, Ishizu T, Saraste A, Stark C, Vähäsilta T, Salminen P, Kirjavainen A, Soinio M, Gastaldelli A, Knuuti J, Iozzo P, Nuutila P. Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity. Diabetologia 2013;56:893-900. [DOI: 10.1007/s00125-012-2825-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
110 Swann OG, Kilpatrick M, Breslin M, Oddy WH. Dietary fiber and its associations with depression and inflammation. Nutr Rev 2020;78:394-411. [PMID: 31750916 DOI: 10.1093/nutrit/nuz072] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 18.0] [Reference Citation Analysis]
111 Nakaoka K, Yamada A, Noda S, Goseki-sone M. Vitamin D-restricted high-fat diet down-regulates expression of intestinal alkaline phosphatase isozymes in ovariectomized rats. Nutrition Research 2018;53:23-31. [DOI: 10.1016/j.nutres.2018.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
112 Shen L, Ji H. Bidirectional interactions between dietary curcumin and gut microbiota. Critical Reviews in Food Science and Nutrition 2019;59:2896-902. [DOI: 10.1080/10408398.2018.1478388] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
113 Alwarith J, Kahleova H, Rembert E, Yonas W, Dort S, Calcagno M, Burgess N, Crosby L, Barnard ND. Nutrition Interventions in Rheumatoid Arthritis: The Potential Use of Plant-Based Diets. A Review. Front Nutr 2019;6:141. [PMID: 31552259 DOI: 10.3389/fnut.2019.00141] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
114 Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, Lähdeaho ML, Linros J, Apter D, Scheinin M, Kloster Smerud H, Rissanen A, Lahtinen S. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine 2016;13:190-200. [PMID: 27810310 DOI: 10.1016/j.ebiom.2016.10.036] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
115 Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, Quintana-Navarro GM, Landa BB, Navas-Cortés JA, Tena-Sempere M, Clemente JC, López-Miranda J, Pérez-Jiménez F, Camargo A. Intestinal Microbiota Is Influenced by Gender and Body Mass Index. PLoS One 2016;11:e0154090. [PMID: 27228093 DOI: 10.1371/journal.pone.0154090] [Cited by in Crossref: 284] [Cited by in F6Publishing: 241] [Article Influence: 56.8] [Reference Citation Analysis]
116 Alexandre A. Suggested involvement of ketone bodies in the pathogenesis of the metabolic syndrome. Med Hypotheses 2013;80:578-81. [PMID: 23466063 DOI: 10.1016/j.mehy.2013.01.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Miura K, Ohnishi H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20:7381-7391. [PMID: 24966608 DOI: 10.3748/wjg.v20.i23.7381] [Cited by in CrossRef: 178] [Cited by in F6Publishing: 142] [Article Influence: 29.7] [Reference Citation Analysis]
118 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397-411. [PMID: 29748586 DOI: 10.1038/s41575-018-0011-z] [Cited by in Crossref: 301] [Cited by in F6Publishing: 251] [Article Influence: 150.5] [Reference Citation Analysis]
119 Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4:1095-1119. [PMID: 23016134 DOI: 10.3390/nu4081095] [Cited by in Crossref: 339] [Cited by in F6Publishing: 280] [Article Influence: 37.7] [Reference Citation Analysis]
120 Lew KN, Starkweather A, Cong X, Judge M. A Mechanistic Model of Gut-Brain Axis Perturbation and High-Fat Diet Pathways to Gut Microbiome Homeostatic Disruption, Systemic Inflammation, and Type 2 Diabetes. Biol Res Nurs 2019;21:384-99. [PMID: 31113222 DOI: 10.1177/1099800419849109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
121 Zinöcker MK, Lindseth IA. The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients 2018;10:E365. [PMID: 29562591 DOI: 10.3390/nu10030365] [Cited by in Crossref: 190] [Cited by in F6Publishing: 148] [Article Influence: 63.3] [Reference Citation Analysis]
122 Beisner J, Filipe Rosa L, Kaden-Volynets V, Stolzer I, Günther C, Bischoff SC. Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides. Front Immunol 2021;12:678360. [PMID: 34177920 DOI: 10.3389/fimmu.2021.678360] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Sharpton SR, Ajmera V, Loomba R. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. Clin Gastroenterol Hepatol 2019;17:296-306. [PMID: 30196156 DOI: 10.1016/j.cgh.2018.08.065] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 20.7] [Reference Citation Analysis]
124 Xu MX, Wang M, Yang WW. Gold-quercetin nanoparticles prevent metabolic endotoxemia-induced kidney injury by regulating TLR4/NF-κB signaling and Nrf2 pathway in high fat diet fed mice. Int J Nanomedicine 2017;12:327-45. [PMID: 28115850 DOI: 10.2147/IJN.S116010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
125 Bowser SM, McMillan RP, Boutagy NE, Tarpey MD, Smithson AT, Osterberg KL, Neilson AP, Davy BM, Davy KP, Hulver MW. Serum endotoxin, gut permeability and skeletal muscle metabolic adaptations following a short term high fat diet in humans. Metabolism 2020;103:154041. [PMID: 31785256 DOI: 10.1016/j.metabol.2019.154041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
126 Zhao C, Chen G, Wang H, Zhao Y, Chai R. Bio-inspired intestinal scavenger from microfluidic electrospray for detoxifying lipopolysaccharide. Bioact Mater 2021;6:1653-62. [PMID: 33313445 DOI: 10.1016/j.bioactmat.2020.11.017] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Norris GH, Milard M, Michalski M, Blesso CN. Protective properties of milk sphingomyelin against dysfunctional lipid metabolism, gut dysbiosis, and inflammation. The Journal of Nutritional Biochemistry 2019;73:108224. [DOI: 10.1016/j.jnutbio.2019.108224] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 13.5] [Reference Citation Analysis]
128 Lamadrid P, Alonso-Peña M, San Segundo D, Arias-Loste M, Crespo J, Lopez-Hoyos M. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. Front Immunol 2021;12:651728. [PMID: 33859644 DOI: 10.3389/fimmu.2021.651728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Su D, Nie Y, Zhu A, Chen Z, Wu P, Zhang L, Luo M, Sun Q, Cai L, Lai Y, Xiao Z, Duan Z, Zheng S, Wu G, Hu R, Tsukamoto H, Lugea A, Liu Z, Pandol SJ, Han YP. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models. Front Physiol 2016;7:498. [PMID: 27895587 DOI: 10.3389/fphys.2016.00498] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 15.8] [Reference Citation Analysis]
130 Jang SE, Hyam SR, Jeong JJ, Han MJ, Kim DH. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways. Br J Pharmacol 2013;170:1078-91. [PMID: 23941302 DOI: 10.1111/bph.12333] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
131 Busnelli M, Manzini S, Jablaoui A, Bruneau A, Kriaa A, Philippe C, Arnaboldi F, Colombo A, Ferrari B, Ambrogi F, Maguin E, Rhimi M, Chiesa G, Gérard P. Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein Diet. Mol Nutr Food Res 2020;64:e1900835. [PMID: 32579743 DOI: 10.1002/mnfr.201900835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
132 Bengmark S. Inflammation and Microbiota and Gut Reconditioning. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2017. pp. 1609-60. [DOI: 10.1002/9783527692156.ch64] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Liu L, Dong W, Wang S, Zhang Y, Liu T, Xie R, Wang B, Cao H. Deoxycholic acid disrupts the intestinal mucosal barrier and promotes intestinal tumorigenesis. Food Funct. 2018;9:5588-5597. [PMID: 30339173 DOI: 10.1039/c8fo01143e] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
134 Hold GL. Western lifestyle: a 'master' manipulator of the intestinal microbiota? Gut 2014;63:5-6. [PMID: 23740189 DOI: 10.1136/gutjnl-2013-304969] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
135 Chapple LS, Deane AM, Heyland DK, Lange K, Kranz AJ, Williams LT, Chapman MJ. Energy and protein deficits throughout hospitalization in patients admitted with a traumatic brain injury. Clin Nutr 2016;35:1315-22. [PMID: 26949198 DOI: 10.1016/j.clnu.2016.02.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 11.2] [Reference Citation Analysis]
136 Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. 2013;6:39-51. [PMID: 23320049 DOI: 10.1177/1756283x12459294] [Cited by in Crossref: 350] [Cited by in F6Publishing: 163] [Article Influence: 43.8] [Reference Citation Analysis]
137 Arias-Loste MT, Fábrega E, López-Hoyos M, Crespo J. The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease. Biomed Res Int 2015;2015:319745. [PMID: 26491664 DOI: 10.1155/2015/319745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
138 Sun WL, Yang JW, Dou HY, Li GQ, Li XY, Shen L, Ji HF. Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis. Bioorg Chem 2021;112:104966. [PMID: 33991837 DOI: 10.1016/j.bioorg.2021.104966] [Reference Citation Analysis]
139 Hashimoto R, Kakigi R, Nakamura K, Itoh S, Daida H, Okada T, Katoh Y. LPS enhances expression of CD204 through the MAPK/ERK pathway in murine bone marrow macrophages. Atherosclerosis 2017;266:167-75. [DOI: 10.1016/j.atherosclerosis.2017.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
140 de La Serre CB, de Lartigue G, Raybould HE. Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol Behav 2015;139:188-94. [PMID: 25446227 DOI: 10.1016/j.physbeh.2014.10.032] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 8.4] [Reference Citation Analysis]
141 Haro C, Garcia-carpintero S, Alcala-diaz JF, Gomez-delgado F, Delgado-lista J, Perez-martinez P, Rangel Zuñiga OA, Quintana-navarro GM, Landa BB, Clemente JC, Lopez-miranda J, Camargo A, Perez-jimenez F. The gut microbial community in metabolic syndrome patients is modified by diet. The Journal of Nutritional Biochemistry 2016;27:27-31. [DOI: 10.1016/j.jnutbio.2015.08.011] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 18.2] [Reference Citation Analysis]
142 Lyte JM, Gabler NK, Hollis JH. Postprandial serum endotoxin in healthy humans is modulated by dietary fat in a randomized, controlled, cross-over study. Lipids Health Dis 2016;15:186. [PMID: 27816052 DOI: 10.1186/s12944-016-0357-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
143 Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis in hepatic disease. Hepatology 2014;59:328-39. [PMID: 23703735 DOI: 10.1002/hep.26494] [Cited by in Crossref: 181] [Cited by in F6Publishing: 173] [Article Influence: 22.6] [Reference Citation Analysis]
144 Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research. Gut Pathog 2013;5:3. [PMID: 23497633 DOI: 10.1186/1757-4749-5-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
145 Mitchell CM, Davy BM, Halliday TM, Hulver MW, Neilson AP, Ponder MA, Davy KP. The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes. Contemp Clin Trials 2015;45:328-37. [PMID: 26520413 DOI: 10.1016/j.cct.2015.10.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
146 Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189. [PMID: 25407511 DOI: 10.1186/s12876-014-0189-7] [Cited by in Crossref: 695] [Cited by in F6Publishing: 565] [Article Influence: 99.3] [Reference Citation Analysis]
147 Zawieja SD, Wang W, Chakraborty S, Zawieja DC, Muthuchamy M. Macrophage alterations within the mesenteric lymphatic tissue are associated with impairment of lymphatic pump in metabolic syndrome. Microcirculation 2016;23:558-70. [PMID: 27588380 DOI: 10.1111/micc.12307] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
148 Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients 2020;12:E944. [PMID: 32235316 DOI: 10.3390/nu12040944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 32.0] [Reference Citation Analysis]
149 Neto JV, de Melo CM, Ribeiro SM. Effects of three-month intake of synbiotic on inflammation and body composition in the elderly: a pilot study. Nutrients 2013;5:1276-86. [PMID: 23595135 DOI: 10.3390/nu5041276] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
150 Katzka DA, Geno DM, Blair HE, Lamsam JL, Alexander JA, Camilleri M. Small intestinal permeability in patients with eosinophilic oesophagitis during active phase and remission. Gut 2015;64:538-43. [PMID: 24957264 DOI: 10.1136/gutjnl-2013-305882] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
151 Elmén L, Zlamal JE, Scott DA, Lee RB, Chen DJ, Colas AR, Rodionov DA, Peterson SN. Dietary Emulsifier Sodium Stearoyl Lactylate Alters Gut Microbiota in vitro and Inhibits Bacterial Butyrate Producers. Front Microbiol 2020;11:892. [PMID: 32499766 DOI: 10.3389/fmicb.2020.00892] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
152 Williams JM, Duckworth CA, Burkitt MD, Watson AJ, Campbell BJ, Pritchard DM. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol 2015;52:445-55. [PMID: 25428410 DOI: 10.1177/0300985814559404] [Cited by in Crossref: 149] [Cited by in F6Publishing: 115] [Article Influence: 21.3] [Reference Citation Analysis]
153 Fond G, Chevalier G, Eberl G, Leboyer M. [The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options]. Presse Med 2016;45:7-19. [PMID: 26653939 DOI: 10.1016/j.lpm.2015.10.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
154 van Baar AC, Nieuwdorp M, Holleman F, Soeters MR, Groen AK, Bergman JJ. The Duodenum harbors a Broad Untapped Therapeutic Potential. Gastroenterology 2018;154:773-7. [DOI: 10.1053/j.gastro.2018.02.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
155 Ortigão R, Pimentel-Nunes P, Dinis-Ribeiro M, Libânio D. Gastrointestinal Microbiome - What We Need to Know in Clinical Practice. GE Port J Gastroenterol 2020;27:336-51. [PMID: 32999906 DOI: 10.1159/000505036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
156 Jin Z, Chen K, Zhou Z, Peng W, Liu W. Roux-en-Y gastric bypass potentially improved intestinal permeability by regulating gut innate immunity in diet-induced obese mice. Sci Rep 2021;11:14894. [PMID: 34290269 DOI: 10.1038/s41598-021-94094-8] [Reference Citation Analysis]
157 Zhang HY, Tian JX, Lian FM, Li M, Liu WK, Zhen Z, Liao JQ, Tong XL. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota. Biomed Pharmacother 2021;133:110857. [PMID: 33197760 DOI: 10.1016/j.biopha.2020.110857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
158 Qu W, Yuan X, Zhao J, Zhang Y, Hu J, Wang J, Li J. Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats. Mol Nutr Food Res 2017;61:1700118. [DOI: 10.1002/mnfr.201700118] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
159 Yeh KL, Kautz A, Lohse B, Groth SW. Associations between Dietary Patterns and Inflammatory Markers during Pregnancy: A Systematic Review. Nutrients 2021;13:834. [PMID: 33806342 DOI: 10.3390/nu13030834] [Reference Citation Analysis]
160 Zhu L, Zhang D, Zhu H, Zhu J, Weng S, Dong L, Liu T, Hu Y, Shen X. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe-/- mice. Atherosclerosis. 2018;268:117-126. [PMID: 29202334 DOI: 10.1016/j.atherosclerosis.2017.11.023] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 18.0] [Reference Citation Analysis]
161 Parolini C. Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System. Mar Drugs 2019;17:E374. [PMID: 31234533 DOI: 10.3390/md17060374] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
162 Moschen AR, Wieser V, Tilg H. Dietary Factors: Major Regulators of the Gut’s Microbiota. Gut Liver. 2012;6:411-416. [PMID: 23170142 DOI: 10.5009/gnl.2012.6.4.411] [Cited by in Crossref: 103] [Cited by in F6Publishing: 82] [Article Influence: 11.4] [Reference Citation Analysis]
163 Noble EE, Hsu TM, Kanoski SE. Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment. Front Behav Neurosci 2017;11:9. [PMID: 28194099 DOI: 10.3389/fnbeh.2017.00009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 25.8] [Reference Citation Analysis]
164 Selber-Hnatiw S, Sultana T, Tse W, Abdollahi N, Abdullah S, Al Rahbani J, Alazar D, Alrumhein NJ, Aprikian S, Arshad R, Azuelos JD, Bernadotte D, Beswick N, Chazbey H, Church K, Ciubotaru E, D'Amato L, Del Corpo T, Deng J, Di Giulio BL, Diveeva D, Elahie E, Frank JGM, Furze E, Garner R, Gibbs V, Goldberg-Hall R, Goldman CJ, Goltsios FF, Gorjipour K, Grant T, Greco B, Guliyev N, Habrich A, Hyland H, Ibrahim N, Iozzo T, Jawaheer-Fenaoui A, Jaworski JJ, Jhajj MK, Jones J, Joyette R, Kaudeer S, Kelley S, Kiani S, Koayes M, Kpata AJAL, Maingot S, Martin S, Mathers K, McCullogh S, McNamara K, Mendonca J, Mohammad K, Momtaz SA, Navaratnarajah T, Nguyen-Duong K, Omran M, Ortiz A, Patel A, Paul-Cole K, Plaisir PA, Porras Marroquin JA, Prevost A, Quach A, Rafal AJ, Ramsarun R, Rhnima S, Rili L, Safir N, Samson E, Sandiford RR, Secondi S, Shahid S, Shahroozi M, Sidibé F, Smith M, Sreng Flores AM, Suarez Ybarra A, Sénéchal R, Taifour T, Tang L, Trapid A, Tremblay Potvin M, Wainberg J, Wang DN, Weissenberg M, White A, Wilkinson G, Williams B, Wilson JR, Zoppi J, Zouboulakis K, Gamberi C. Metabolic networks of the human gut microbiota.Microbiology (Reading). 2020;166:96-119. [PMID: 31799915 DOI: 10.1099/mic.0.000853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
165 Siracusa F, Schaltenberg N, Villablanca EJ, Huber S, Gagliani N. Dietary Habits and Intestinal Immunity: From Food Intake to CD4+ T H Cells. Front Immunol 2018;9:3177. [PMID: 30697217 DOI: 10.3389/fimmu.2018.03177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
166 Christ A, Bekkering S, Latz E, Riksen NP. Long-term activation of the innate immune system in atherosclerosis. Semin Immunol 2016;28:384-93. [PMID: 27113267 DOI: 10.1016/j.smim.2016.04.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
167 Usuda H, Okamoto T, Wada K. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier. Int J Mol Sci 2021;22:7613. [PMID: 34299233 DOI: 10.3390/ijms22147613] [Reference Citation Analysis]
168 Wang J, Zhao H, Lv K, Zhao W, Zhang N, Yang F, Wen X, Jiang X, Tian J, Liu X, Ho C, Li S. Pterostilbene Ameliorates DSS-Induced Intestinal Epithelial Barrier Loss in Mice via Suppression of the NF-κB-Mediated MLCK-MLC Signaling Pathway. J Agric Food Chem 2021;69:3871-8. [DOI: 10.1021/acs.jafc.1c00274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J Clin Oncol. 2016;34:4270-4276. [PMID: 27903155 DOI: 10.1200/jco.2016.67.4283] [Cited by in Crossref: 233] [Cited by in F6Publishing: 149] [Article Influence: 46.6] [Reference Citation Analysis]
170 Janssen AWF, Kersten S. The role of the gut microbiota in metabolic health. The FASEB Journal 2015;29:3111-23. [DOI: 10.1096/fj.14-269514] [Cited by in Crossref: 99] [Cited by in F6Publishing: 77] [Article Influence: 16.5] [Reference Citation Analysis]
171 Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66:1138-1153. [PMID: 28314735 DOI: 10.1136/gutjnl-2017-313884] [Cited by in Crossref: 384] [Cited by in F6Publishing: 319] [Article Influence: 96.0] [Reference Citation Analysis]
172 Vozenilek AE, Navratil AR, Green JM, Coleman DT, Blackburn CMR, Finney AC, Pearson BH, Chrast R, Finck BN, Klein RL, Orr AW, Woolard MD. Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis. Arterioscler Thromb Vasc Biol 2018;38:324-34. [PMID: 29217509 DOI: 10.1161/ATVBAHA.117.310455] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
173 He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci 2017;7:54. [PMID: 29090088 DOI: 10.1186/s13578-017-0183-1] [Cited by in Crossref: 117] [Cited by in F6Publishing: 91] [Article Influence: 29.3] [Reference Citation Analysis]
174 Ahmad R, Rah B, Bastola D, Dhawan P, Singh AB. Obesity-induces Organ and Tissue Specific Tight Junction Restructuring and Barrier Deregulation by Claudin Switching. Sci Rep. 2017;7:5125. [PMID: 28698546 DOI: 10.1038/s41598-017-04989-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
175 Luo Z, Ji Y, Gao H, Gomes Dos Reis FC, Bandyopadhyay G, Jin Z, Ly C, Chang YJ, Zhang D, Kumar D, Ying W. CRIg+ Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance. Gastroenterology 2021;160:863-74. [PMID: 33152356 DOI: 10.1053/j.gastro.2020.10.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Sharifov OF, Nayyar G, Ternovoy VV, Mishra VK, Litovsky SH, Palgunachari MN, Garber DW, Anantharamaiah GM, Gupta H. Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats. Biochem Biophys Res Commun 2013;436:705-10. [PMID: 23791744 DOI: 10.1016/j.bbrc.2013.06.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
177 Stenman LK, Holma R, Gylling H, Korpela R. Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity. Br J Nutr 2013;110:1157-64. [PMID: 23442231 DOI: 10.1017/S000711451300024X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
178 Blumberg JB, Basu A, Krueger CG, Lila MA, Neto CC, Novotny JA, Reed JD, Rodriguez-Mateos A, Toner CD. Impact of Cranberries on Gut Microbiota and Cardiometabolic Health: Proceedings of the Cranberry Health Research Conference 2015. Adv Nutr 2016;7:759S-70S. [PMID: 27422512 DOI: 10.3945/an.116.012583] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
179 Tong Y, Gao H, Qi Q, Liu X, Li J, Gao J, Li P, Wang Y, Du L, Wang C. High fat diet, gut microbiome and gastrointestinal cancer. Theranostics 2021;11:5889-910. [PMID: 33897888 DOI: 10.7150/thno.56157] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Gnauck A, Lentle RG, Kruger MC. Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci 2016;53:197-215. [PMID: 26732012 DOI: 10.3109/10408363.2015.1123215] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
181 Takai A, Kikuchi K, Ichimura M, Tsuneyama K, Moritoki Y, Matsumoto K, Tsunashima H, Onda T, Kuniyoshi N, Nariyama T, Ohyatsu S, Kubota J, Nagumo K, Sato S, Hara M, Miyakawa H. Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol. 2020;20:46. [PMID: 32103741 DOI: 10.1186/s12876-020-01194-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
182 de Faria Ghetti F, Oliveira DG, de Oliveira JM, de Castro Ferreira LEVV, Cesar DE, Moreira APB. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. Eur J Nutr. 2018;57:861-876. [PMID: 28875318 DOI: 10.1007/s00394-017-1524-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 10.8] [Reference Citation Analysis]
183 Espírito Santo C, Caseiro C, Martins MJ, Monteiro R, Brandão I. Gut Microbiota, in the Halfway between Nutrition and Lung Function. Nutrients 2021;13:1716. [PMID: 34069415 DOI: 10.3390/nu13051716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Song J, Li T, Cheng X, Ji X, Gao D, Du M, Jiang N, Liu X, Mao X. Sea cucumber peptides exert anti-inflammatory activity through suppressing NF-κB and MAPK and inducing HO-1 in RAW264.7 macrophages. Food Funct 2016;7:2773-9. [PMID: 27220344 DOI: 10.1039/c5fo01622c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
185 Dong TS, Jacobs JP. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver? Exp Biol Med (Maywood) 2019;244:408-18. [PMID: 30871368 DOI: 10.1177/1535370219836739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
186 Uyar GÖ, Yildiran H. A nutritional approach to microbiota in Parkinson's disease. Biosci Microbiota Food Health 2019;38:115-27. [PMID: 31763115 DOI: 10.12938/bmfh.19-002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
187 Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N, Dickerson F, Macgregor A, Boyer L, Dargel A. The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review. Pathol Biol (Paris). 2015;63:35-42. [PMID: 25468489 DOI: 10.1016/j.patbio.2014.10.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 84] [Article Influence: 15.6] [Reference Citation Analysis]
188 Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology 2015;148:1107-19. [PMID: 25575570 DOI: 10.1053/j.gastro.2014.12.036] [Cited by in Crossref: 158] [Cited by in F6Publishing: 115] [Article Influence: 26.3] [Reference Citation Analysis]
189 Tran A, Gual P. Non-alcoholic steatohepatitis in morbidly obese patients. Clin Res Hepatol Gastroenterol. 2013;37:17-29. [PMID: 23347840 DOI: 10.1016/j.clinre.2012.07.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
190 Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions. ACS Infect Dis 2021;7:987-1009. [PMID: 33848139 DOI: 10.1021/acsinfecdis.0c00839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
191 Houghton D, Stewart CJ, Day CP, Trenell M. Gut Microbiota and Lifestyle Interventions in NAFLD. Int J Mol Sci. 2016;17:447. [PMID: 27023533 DOI: 10.3390/ijms17040447] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 9.4] [Reference Citation Analysis]
192 do Rosario VA, Fernandes R, Trindade EB. Vegetarian diets and gut microbiota: important shifts in markers of metabolism and cardiovascular disease. Nutr Rev. 2016;74:444-454. [PMID: 27261272 DOI: 10.1093/nutrit/nuw012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
193 Napier BA, Andres-Terre M, Massis LM, Hryckowian AJ, Higginbottom SK, Cumnock K, Casey KM, Haileselassie B, Lugo KA, Schneider DS, Sonnenburg JL, Monack DM. Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome. Proc Natl Acad Sci U S A 2019;116:3688-94. [PMID: 30808756 DOI: 10.1073/pnas.1814273116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
194 Ha CW, Lam YY, Holmes AJ. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol. 2014;20:16498-16517. [PMID: 25469018 DOI: 10.3748/wjg.v20.i44.16498] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 57] [Article Influence: 10.8] [Reference Citation Analysis]
195 Dixon LJ, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2015;21:912-22. [PMID: 25581832 DOI: 10.1097/MIB.0000000000000289] [Cited by in Crossref: 54] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
196 Qiao J, Wu Y, Ren Y. The impact of a high fat diet on bones: potential mechanisms. Food Funct 2021;12:963-75. [DOI: 10.1039/d0fo02664f] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
197 Guthrie GJ, Aydemir TB, Troche C, Martin AB, Chang SM, Cousins RJ. Influence of ZIP14 (slc39A14) on intestinal zinc processing and barrier function. Am J Physiol Gastrointest Liver Physiol 2015;308:G171-8. [PMID: 25428902 DOI: 10.1152/ajpgi.00021.2014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 7.9] [Reference Citation Analysis]
198 Zhang L, Wang F, Wang J, Wang Y, Fang Y. Intestinal fatty acid-binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability. J Cell Mol Med 2020;24:5205-12. [PMID: 32220004 DOI: 10.1111/jcmm.15173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
199 Santos HO, Howell S, Earnest CP, Teixeira FJ. Coconut oil intake and its effects on the cardiometabolic profile – A structured literature review. Progress in Cardiovascular Diseases 2019;62:436-43. [DOI: 10.1016/j.pcad.2019.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
200 Guillemot-legris O, Muccioli GG. Obesity-Induced Neuroinflammation: Beyond the Hypothalamus. Trends in Neurosciences 2017;40:237-53. [DOI: 10.1016/j.tins.2017.02.005] [Cited by in Crossref: 214] [Cited by in F6Publishing: 160] [Article Influence: 53.5] [Reference Citation Analysis]
201 Ogawa Y, Imajo K, Honda Y, Kessoku T, Tomeno W, Kato S, Fujita K, Yoneda M, Saito S, Saigusa Y, Hyogo H, Sumida Y, Itoh Y, Eguchi K, Yamanaka T, Wada K, Nakajima A. Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. Sci Rep 2018;8:11365. [PMID: 30054551 DOI: 10.1038/s41598-018-29735-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
202 Haque TR, Barritt AS. Intestinal microbiota in liver disease. Best Practice & Research Clinical Gastroenterology 2016;30:133-42. [DOI: 10.1016/j.bpg.2016.02.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
203 Zhang Q, Yu H, Xiao X, Hu L, Xin F, Yu X. Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats. PeerJ. 2018;6:e4446. [PMID: 29507837 DOI: 10.7717/peerj.4446] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 20.7] [Reference Citation Analysis]
204 Luche E, Cousin B, Garidou L, Serino M, Waget A, Barreau C, André M, Valet P, Courtney M, Casteilla L, Burcelin R. Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Mol Metab 2013;2:281-91. [PMID: 24049740 DOI: 10.1016/j.molmet.2013.06.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
205 Suliman HM, Osman B, Abdoon IH, Saad AM, Khalid H. Ameliorative activity of Adansonia digitata fruit on high sugar/high fat diet-simulated Metabolic Syndrome model in male Wistar rats. Biomed Pharmacother 2020;125:109968. [PMID: 32066041 DOI: 10.1016/j.biopha.2020.109968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
206 Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surgery for Obesity and Related Diseases 2015;11:45-53. [DOI: 10.1016/j.soard.2014.05.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
207 Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol 2017;23:5669-79. [PMID: 28883692 DOI: 10.3748/wjg.v23.i31.5669] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
208 Gonçalves de Carvalho CM, Ribeiro SM. Aging, low-grade systemic inflammation and vitamin D: a mini-review. Eur J Clin Nutr 2017;71:434-40. [PMID: 27677370 DOI: 10.1038/ejcn.2016.177] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 6.4] [Reference Citation Analysis]
209 Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15:425-439. [PMID: 29713021 DOI: 10.1038/s41575-018-0010-0] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 42.5] [Reference Citation Analysis]
210 Schippa S, Conte MP. Dysbiotic events in gut microbiota: impact on human health. Nutrients 2014;6:5786-805. [PMID: 25514560 DOI: 10.3390/nu6125786] [Cited by in Crossref: 96] [Cited by in F6Publishing: 79] [Article Influence: 13.7] [Reference Citation Analysis]
211 de Oliveira GHP, de Moura DTH, Funari MP, McCarty TR, Ribeiro IB, Bernardo WM, Sagae VMT, Freitas JR Jr, Souza GMV, de Moura EGH. Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis. Obes Surg. 2021;31:1304-1312. [PMID: 33417100 DOI: 10.1007/s11695-020-05170-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
212 Spreadbury I. Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes 2012;5:175-89. [PMID: 22826636 DOI: 10.2147/DMSO.S33473] [Cited by in Crossref: 51] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
213 Haque SZ, Haque M. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal. Clin Exp Gastroenterol 2017;10:91-103. [PMID: 28503071 DOI: 10.2147/CEG.S126243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
214 Moludi J, Maleki V, Jafari‐vayghyan H, Vaghef‐mehrabany E, Alizadeh M. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol 2020;47:927-39. [DOI: 10.1111/1440-1681.13250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 20.0] [Reference Citation Analysis]
215 Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3:207-215. [PMID: 25066177 DOI: 10.1016/s2213-8587(14)70134-2] [Cited by in Crossref: 317] [Cited by in F6Publishing: 150] [Article Influence: 45.3] [Reference Citation Analysis]
216 Marrone MC, Coccurello R. Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases. Biomolecules 2019;10:E12. [PMID: 31861745 DOI: 10.3390/biom10010012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
217 André P, Pais de Barros JP, Mj Merle B, Samieri C, Helmer C, Delcourt C, Féart C. Mediterranean diet and prudent diet are both associated with low circulating esterified 3-hydroxy fatty acids, a proxy of LPS burden, among older adults. Am J Clin Nutr 2021:nqab126. [PMID: 34036325 DOI: 10.1093/ajcn/nqab126] [Reference Citation Analysis]
218 Xie Y, Matsumoto H, Nalbantoglu I, Kerr TA, Luo J, Rubin DC, Kennedy S, Davidson NO. Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer. PLoS One 2013;8:e67819. [PMID: 23805328 DOI: 10.1371/journal.pone.0067819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
219 Hyam SR, Jang S, Jeong J, Joh E, Han MJ, Kim D. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice. International Immunopharmacology 2013;15:433-41. [DOI: 10.1016/j.intimp.2012.12.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
220 Rajamanickam A, Munisankar S, Menon PA, Dolla C, Nutman TB, Babu S. Helminth Mediated Attenuation of Systemic Inflammation and Microbial Translocation in Helminth-Diabetes Comorbidity. Front Cell Infect Microbiol 2020;10:431. [PMID: 32984066 DOI: 10.3389/fcimb.2020.00431] [Reference Citation Analysis]
221 Zhu TB, Zhang Z, Luo P, Wang SS, Peng Y, Chu SF, Chen NH. Lipid metabolism in Alzheimer's disease. Brain Res Bull 2019;144:68-74. [PMID: 30472149 DOI: 10.1016/j.brainresbull.2018.11.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
222 Dogan S, Celikbilek M, Guven K. High fructose consumption can induce endotoxemia. Gastroenterology 2012;143:e29. [PMID: 22841729 DOI: 10.1053/j.gastro.2012.07.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
223 Kang M, Edmundson P, Araujo-Perez F, McCoy AN, Galanko J, Keku TO. Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer 2013;13:91. [PMID: 23442743 DOI: 10.1186/1471-2407-13-91] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
224 Wu H, Ballantyne CM. Metabolic Inflammation and Insulin Resistance in Obesity.Circ Res. 2020;126:1549-1564. [PMID: 32437299 DOI: 10.1161/CIRCRESAHA.119.315896] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 49.0] [Reference Citation Analysis]
225 Ott B, Skurk T, Lagkouvardos L, Fischer S, Büttner J, Lichtenegger M, Clavel T, Lechner A, Rychlik M, Haller D, Hauner H. Short-Term Overfeeding with Dairy Cream Does Not Modify Gut Permeability, the Fecal Microbiota, or Glucose Metabolism in Young Healthy Men. J Nutr 2018;148:77-85. [PMID: 29378051 DOI: 10.1093/jn/nxx020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
226 Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front Immunol 2020;11:571731. [PMID: 33178196 DOI: 10.3389/fimmu.2020.571731] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
227 Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013;27:73-83. [PMID: 23768554 DOI: 10.1016/j.bpg.2013.03.007] [Cited by in Crossref: 323] [Cited by in F6Publishing: 267] [Article Influence: 40.4] [Reference Citation Analysis]